Phase I/II trial of high-dose cytosine arabinoside and mitoxantrone in adult refractory acute myeloid leukemia.
Hiddemann
W
W
Kreutzmann
H
H
Straif
K
K
Ludwig
W D
WD
Fuhr
H J
HJ
Donhuijsen-Ant
R
R
Lengfelder
E
E
Büchner
T
T
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005860:Germany, West; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008942:Mitoxantrone / Q000008:administration & dosage
D003561:Cytarabine; D008942:Mitoxantrone